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ABSTRACT 27 
Background: Plantar fasciopathy is the most common cause of acquired 28 
sub-calcaneal heel pain in adults. To-date, research of this condition has 29 
mainly focused on management rather than causal mechanisms. The 30 
aetiology of plantar fasciopathy is likely to be multifactorial, as both 31 
intrinsic and extrinsic risk factors have been reported. The purpose of this 32 
review is to critically reevaluate risk factors for plantar fasciopathy.  33 
Methods: A detailed literature review was undertaken using English 34 
language medical databases.  35 
Results: No clear consensus exists as to the relative strength of the risk 36 
factors reported.  37 
Conclusions: To-date numerous studies have examined various intrinsic 38 
and extrinsic risk factors implicated in the aetiology of plantar fasciopathy. 39 
How these factors interact may provide useful data to establish an 40 
individuals’ risk profile for plantar fasciopathy and their potential for 41 
response to treatment. Further research is indicated to rank the relative 42 
significance of these risk factors. 43 
 44 
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INTRODUCTION  53 
Similar to other conditions where pathological origin is unclear, chronic 54 
plantar heel pain has become a generalized term that includes several 55 
pathological conditions that affect the heel.[1] Heel pain may be the result 56 
of arthritic, neurological, traumatic, or other systemic conditions, although 57 
the overwhelming cause is mechanical in origin.[2, 3] 58 
Plantar fasciitis is a commonly reported cause of plantar heel pain.[4-7] 59 
Terminology for this condition is confusing, as a degenerative process of 60 
micro tears (fasciosis) similar to tendinosis, a degeneration of collagen in 61 
tendons[8], and fascial thickening predominates over inflammatory 62 
changes. Similar histopathological changes have been reported in tendon 63 
and ligament disorders elsewhere[8] hence redefinition of the condition 64 
from plantar fasciitis to plantar fasciopathy (PF) may better reflect the 65 
underlying pathology within the fascia, which rarely includes inflammatory 66 
cells.  67 
The purpose of this paper is to critically reevaluate risk factors for PF. 68 
 69 
BACKGROUND 70 
Relevant clinical aspects of PF are included to help support the discussion 71 
of risk factors. 72 
Diagnosis   73 
There is no widely accepted test or ‘gold standard’ for diagnosing PF.[9] 74 
Ultrasound can be used to confirm clinical diagnosis and classify the 75 
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disease pattern. Ultrasound diagnosis of PF includes reduced 76 
echogenicity[9] and plantar fascia thickening (>4-4.5mm) at its calcaneal 77 
insertion[10-12]. Jeong et al[13] also found discrete fibromata and thickening 78 
in those with pure distal (non-insertional disease). More importantly there 79 
is disorganization of the normal reflective structure and loss of normal 80 
organized ligament architecture.[9]  81 
 82 
Classification 83 
Jeong et al[13] examined 125 consecutive feet with symptoms of 84 
recalcitrant PF. All had failed to respond to a stepwise conservative 85 
management protocol. Disease characteristics were evaluated using 86 
diagnostic ultrasound. A high proportion of atypical non-insertional PF was 87 
reported.[13] This would not be detected without imaging studies. The use 88 
of ultrasound in cases of recalcitrant plantar heel pain that have failed 89 
proper first-line management is recommended.[12, 13] It was concluded 90 
that ultrasound confirmed clinical diagnosis and classification 91 
characteristics as either insertional (proximal), non-insertional (distal) or 92 
mixed disease PF.[13]  93 
 94 
Clinical picture 95 
Plantar fasciopathy is a clinical diagnosis, characterized by the insidious 96 
onset of plantar heel pain after prolonged periods of rest.[2, 6] It is usually 97 
worse in the morning after the first few steps or starting to walk after a 98 
period of inactivity. Although walking helps initially, the pain can recur 99 
Page 5 of 28
Ac
ce
pte
d M
an
us
cri
pt
 5 
with further exertion. Some patients complain of pain on toe extension 100 
due to invocation of the windlass mechanism[5]. Pain may worsen towards 101 
the end of the day and with increased weight-bearing activity.[14] 102 
Although patients exhibit similar patterns of symptoms, the clinical 103 
presentation can vary in location, level of pain and duration.[15] Up to one 104 
third of patients with PF will present with bilateral symptoms.[16, 17] The 105 
condition affects both sedentary[18-20] and athletic individuals[21, 22], 106 
including military personnel[23, 24]; as such a diverse patient population is 107 
observed. The condition has been reported to peak between 40 to 60 108 
years-of-age.[6] 109 
 110 
Prevalence 111 
The prevalence of heel pain in the general population is estimated to 112 
range from 3.6% to 7%[20-22], and the disorder has been reported to 113 
account for about 8% of all running related injuries.[25, 26] A retrospective 114 
review of 1407 patients from an outpatient sports medicine clinic, found 115 
that younger athletes had a lower prevalence of PF (2.5%) than older 116 
athletes (6.6%).[27] The literature is inconsistent regarding the association 117 
between gender and PF. Some studies show an increased prevalence in 118 
men[24]; while others show greater prevalence in women.[18, 22] 119 
Plantar fasciopathy is commonly described as a self-limiting condition.[5,6] 120 
Crawford & Thomson[28] undertook a systematic review supporting this 121 
observation. However, PF can be a painful and disabling condition with 122 
detrimental effects on health-related quality of life and subsequently be 123 
frustrating for patients. There is a higher risk of prolonged symptoms in 124 
overweight patients[29], those with bilateral involvement and when there 125 
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is a long delay before seeking medical attention.[30, 31] 126 
 127 
Impact on health 128 
Patients are unlikely to be satisfied with evidence of the self-limiting 129 
nature of the condition and most are likely to demand treatment for their 130 
symptoms.[32] Irving et al[33] demonstrated that chronic heel pain has a 131 
significant negative impact on foot-specific and general health-related 132 
quality of life. The degree of negative impact does not seem to be 133 
associated with age, sex, or BMI.[33] Physical inactivity is recognized as 134 
one of the greatest public health challenges in Western countries.[34] The 135 
morbidity of PF can result in immobility and reduced activity levels.[33] 136 
Furthermore, patients who develop PF are often overweight and therefore 137 
subsequent loss of weight becomes increasingly difficulty due to the pain 138 
of everyday weight bearing.[35] The duration of obesity in obese patients 139 
may be important to the development of heel pain in such patients. 140 
Inactivity and an increased body weight are major risk factors for many 141 
diseases such as obesity, cardiovascular disease, diabetes and 142 
osteoarthritis making it imperative that treatment for PF is instituted 143 
rather than waiting for spontaneous resolution.  144 
 145 
Economic burden 146 
Plantar fasciopathy is an important public health disorder due to its 147 
frequent occurrence.[5] Researchers have estimated that 10% of people in 148 
the USA may present with heel pain over the course of their lives, with 149 
83% of these patients being active working adults.[36, 37] With people 150 
working and living longer the age range for this condition may be 151 
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potentially extending. An estimated one million visits per year were made 152 
to physicians and hospital outpatients in the USA for treatment of PF, 153 
representing an important economic burden to health services.[37] 154 
Frequently, patients do not seek treatment until symptoms are considered 155 
chronic. At this point treatment regimens can become costly, as 156 
symptoms are recurring, recovery is lengthy and the response to 157 
treatment is unpredictable.[31] Furthermore the potential for longer-term 158 
health consequences related to immobility such as weight-gain, 159 
hypertension, coronary artery disease and non-insulin dependent diabetes 160 
in chronic PF exist.  161 
 162 
METHODS 163 
The following criteria were used to search the literature: 164 
1. English language human studies. 165 
2. Published after 1988. 166 
3. Electronic databases: Cochrane library, BioMed Central, EMBASE, 167 
CINAHL, AMED, Ovid, Swetswise, PubMed, Highwire, SportDiscus, ISI 168 
web of knowledge, Science direct, Science citation index, The 169 
Lancet.com, BMJ clinical evidence, MEDLINE, Scirus.com, Index to 170 
thesis, Controlledtrials.com UK national research register for on-going/ 171 
recently completed trials.  172 
4. MeSH terms used alone or in combination: plantar fasciitis, fasciopathy, 173 
sub-calcaneal, heel pain, aetiology, risk factors. 174 
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5. Search limited to: peer-reviewed journals, systematic reviews/ meta-175 
analyses, cohort studies, case control studies and surveys. Case reports 176 
and letter to editors were excluded. 177 
6. Research papers were chosen based upon evaluation of PF risk factors. 178 
7. Series with n > 10. 179 
8. Results for each risk factor were separable if > 1 discussed. 180 
 181 
 182 
DISCUSSION 183 
Although PF is the most common soft-tissue cause of heel pain[5, 19] its 184 
aetiology is not fully understood.[22, 38, 39, 40, 41] The condition is considered 185 
to be multifactorial[6, 17, 20] and numerous risk factors are implicated in its 186 
development (Table 1). The evidence supporting these factors is limited 187 
and their relative importance is unclear. Several causes have been 188 
hypothesized, with the most common being overuse due to prolonged 189 
weight-bearing, obesity, unaccustomed walking or running, limited ankle 190 
joint dorsiflexion, posterior muscle group tightness and standing on hard 191 
surfaces.[2, 5, 19, 20, 32, 40, 41, 51] 192 
The presence of co-existing calcaneal spurs has often been reported[9, 11, 193 
14, 42] but confusion exists as to whether it is a causal or significant 194 
association. Some suggest that calcaneal spurs may be an adaptive 195 
response to vertical compression of the heel rather than longitudinal 196 
traction at the calcaneal enthesis[43]. A study examining prehistoric 197 
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skeletal remains[44] concludes that plantar calcaneal spurs are a modern 198 
phenomenon resulting from long periods of standing, excess weight and 199 
associated with lower limb osteoarthritis. Wainwright et al[42] reported a 200 
strong correlation with calcaneal spurs over 1mm long and PF and Johal & 201 
Milner[45] found a higher prevalence of calcaneal spurs in patients with PF. 202 
Further research is warranted to assess whether the association is 203 
causal.[44]  204 
Typically PF affects middle-aged or older people, often women more than 205 
men. The association of PF with increasing age is consistent with the 206 
histopathological findings of degenerative changes within the plantar 207 
fascia.[38] These degenerative findings support the hypothesis that PF is 208 
secondary to repetitive micro trauma caused by prolonged weight-bearing 209 
activities.[52] The constant overload inhibits the normal repair process, 210 
resulting in collagen degeneration, which causes both structural changes 211 
and perifascial oedema.[1] These changes in turn lead to a thicker heel 212 
pad, which has been shown to be associated with pain in individuals with 213 
PF.[52] Increasing heel pad thickness leads to a loss of heel pad elasticity; 214 
both of these factors are associated with increasing age and increasing 215 
BMI.[53, 54] The decrease in elasticity of the fascia seen with increasing age 216 
is associated with a decrease in shock absorbing capabilities[54], which 217 
may be a result of the degenerative fascia’s inability to resist normal 218 
tensile loads.  219 
The current literature is inconsistent regarding the association between 220 
gender and PF (Table 1). No theories exist hypothesizing the reason for a 221 
difference in prevalence between the sexes. This may relate to hormonal 222 
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differences or structural changes like those seen in tendinopathy or 223 
differences caused by genetic variations. 224 
Increased body weight [53] and increased body mass index (BMI)[19, 29] 225 
have been shown to be significant risk factors for PF (Table 1). A BMI of 226 
more than 30 kg/m2 having an odds ratio of 5.6 (95% confidence interval, 227 
1.9 to 16.6; p < 0.01) compared with a BMI of less than 25 kg/m2 228 
[19].  Rano et al[29] also concluded that a BMI of 25 (the target for 229 
cardiovascular risk) represents a reasonable goal for weight loss that may 230 
reduce heel pain. Frey and Zamora [55] demonstrated a 1.4-fold increased 231 
probability of PF being diagnosed in an overweight or obese patient.[55] 232 
Rome et al[52] suggested that BMI is not related to plantar fasciitis pain in 233 
the athletic population, but other factors such as a low oestrogen levels in 234 
female athletes which  leads to reduced collagen elasticity.[52] 235 
Previous research has suggested that limited ankle dorsiflexion[30], 236 
obesity[29] and prolonged weight bearing[19] may increase the risk of PF. 237 
Those studies, however, involved the use of univariate analytical 238 
approaches and, in some cases, did not include a control group. Riddle et 239 
al[19] hypothesized that reduced ankle dorsiflexion is the most important 240 
risk factor for development of PF and reported that individuals with <0o of 241 
dorsiflexion have an odds ratio of 23.3 (95% CI 4.3-124.4).[19] Riddle et 242 
al[19] hypothesized that increased ankle equinus can result in more 243 
compensatory foot pronation and subsequently greater tensile loading on 244 
the plantar fascia. Limited ankle dorsiflexion appears to have a biologically 245 
plausible explanation for causality. Individuals who spend the majority of 246 
the workday weight-bearing and those who are obese also theoretically 247 
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have increased tensile loads on the plantar fascia compared with those 248 
who spend less time weight-bearing and those who have a normal body 249 
weight.  250 
It is unclear whether limited ankle dorsiflexion is a cause or a 251 
consequence of PF. It is possible that limited dorsiflexion may develop 252 
after the onset of the disorder. Theoretically, if PF had caused the loss of 253 
dorsiflexion, then the motion on the involved side would have been 254 
reduced and the motion on the uninvolved side would not have been 255 
reduced. Riddle et al[19] undertook a case-control study where only cases 256 
of unilateral PF were used. The uninvolved side was used as the control 257 
for ankle joint dorsiflexion. It was found that dorsiflexion on the 258 
uninvolved side was also reduced relative to that in the control group.[19] 259 
A “dose-response” relationship was found for the risk factor of limited 260 
dorsiflexion on the uninvolved side.[19] Thus it was hypothesized that 261 
ankle dorsiflexion may have been limited before the onset of the 262 
disorder.[19] 263 
More recently Bolivar et al[51] found an association between posterior leg 264 
muscle tightness (hamstring as well as triceps surae) and PF in a 265 
controlled trial of 100 participants. Labovitz et al[56] and Harty et al[46] also 266 
found an association with hamstring tightness and PF. Harty et al[46]  267 
concluded that this was found to prolong forefoot loading and through the 268 
windlass mechanism might be a factor that increases repetitive injury to 269 
the plantar fascia.  270 
The most common cause cited for plantar heel pain is biomechanical 271 
stress of the plantar fascia at its enthesis of the calcaneal tuberosity. 272 
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Mechanical overload, whether the result of biomechanical faults, obesity, 273 
or occupation, may contribute to the symptoms of heel pain.[2] Foot 274 
pronation alone, as measured by the Foot Posture Index[57] has also been 275 
shown to be significantly greater in patients with chronic plantar heel 276 
pain.[16] This is supported by Lee et al[47]  who demonstrated a high 277 
correlation between arch height (r = 0.642), plantar fascia tension (r = -278 
0.797) maximum rearfoot eversion (r = -0.518). It is hypothesized that a 279 
lack of cushioning in a rigid high arched foot may also result in PF but this 280 
has not been proven.[5] 281 
Stress shielding (failure of a stress deprived deep structure to heal 282 
because of the superficial element bearing most of the load) has been 283 
implicated in enthesopathy.[14] It has been suggested that that proximal 284 
tendinopathy of the flexor digitorum brevis muscle (which is deep to the 285 
plantar fascial ligament) is implicated in the pathology of PF.[14]    286 
Localized nerve entrapment of the medial calcaneal or muscular (first) 287 
branch of the lateral plantar (Baxter’s) nerve may be a contributory factor 288 
to plantar heel pain.[2] The presence of sensory disturbances including 289 
radiation of pain is indicative of neurological pathology thereby 290 
differentiating it from PF. 291 
Work-related prolonged weight bearing has been reported to be 292 
associated with PF.[19, 23, 35, 40]. Riddle et al[19] found a significant 293 
association (OR 3.6, 95% CI 1.3-10.0) of the reported cases of PF with 294 
time spent working on feet (>80% of work day).[19] There was however, 295 
no data presented on the extent and duration of exposure; nor the 296 
particular occupations and work histories of the cases and controls. 297 
Page 13 of 28
Ac
ce
pte
d M
an
us
cri
pt
 13 
Inappropriate footwear[5, 19, 48] and rapid increases in activity levels[5, 19] 298 
have also been reported as risk factors associated with PF. 299 
In athletes PF is primarily believed to be an overuse injury combined with 300 
training errors, training surfaces, biomechanical alignment and muscle 301 
dysfunction and inflexibility.[5, 22, 25, 26] Additionally, PF has been 302 
associated with individuals engaging in sports involving jumping.[1] 303 
Excessive foot pronation can lead to increased plantar fascial tension 304 
during the stance phase of running.[25, 26] Furthermore, heel strike during 305 
running causes compression of the heel pad up to twice body weight.[5] 306 
For athletes with inadequate muscle strength or flexibility and decreased 307 
shock-absorbing capabilities, the initiation of a new training program may 308 
exacerbate overloading of the plantar fascia.[24] Increases in tensile 309 
loading, seen with new increases in running intensity or frequency and 310 
changes in general footwear have been associated with overloads of the 311 
plantar fascia leading to micro tears.[30] In particular, firm footwear may 312 
exacerbate the developing PF in such patients.[23]  313 
These risk factors combine to create a pathological overload of the plantar 314 
fascia at its origin, causing micro tears[49] in the fascia that subsequently 315 
lead to perifascial odema and increasing heel pad thickness.[20, 38, 52] As 316 
these micro tears increase in size, they may coalesce to form a large 317 
symptomatic mass causing an increase in heel pad thickness.[52] These 318 
changes in fascial thickening[50] (particularly proximal portion), and 319 
oedema of the adjacent fat pad and underlying soft tissues can typically 320 
be seen on ultrasound or MRI.[1]  321 
To-date no research has considered a possible genetic basis to PF. 322 
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Candidate gene variants for tendinopathy (a degenerative process not 323 
dissimilar to PF) have been examined and various associations 324 
revealed.[58-64]. Some of the candidate gene variants based on tendon 325 
studies may also be relevant to ligaments such as the plantar fascia 326 
(Table 1). As in tendinopathy[60] a range of candidate gene variants may 327 
also contribute to the development of PF. Individuals may possess certain 328 
genetic risk factors that predispose them to PF. These genetic factors may 329 
interact with other factors (intrinsic and extrinsic) to increase their overall 330 
risk profile for developing PF. Research to examine a possible genetic 331 
basis for PF may add to our understanding of the intrinsic risk profile for 332 
this condition. Furthermore, it may help to predict the patients at risk 333 
from developing chronic PF.  334 
Inflammatory disease[65-67] or drug therapy may also be implicated in the 335 
development of PF[68] in a few cases that is unresponsive to common 336 
conservative interventions. 337 
 338 
CONCLUSION 339 
Plantar fasciopathy is a common cause of sub calcaneal heel pain. The 340 
condition represents an important economic burden to health services due 341 
its potential to become chronic in nature. Studies supporting both intrinsic 342 
and extrinsic risk factors suggest complex multifactorial soft tissue 343 
pathology. Research to examine a possible genetic basis for developing 344 
this condition may advance our knowledge of the intrinsic risk profile, 345 
provide a novel and alternative approach to understanding this 346 
challenging condition and help rank the significance of risk factors. 347 
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Table 1: Risk factors for plantar fasciitis  
 
INTRINSIC  EXTRINSIC  
Increased age:  
- Average age at presentation 10 yrs higher than controls who presented 
for other reasons.[29] 
- Increased prevalence in older athletes.[27] 
- Age related degenerative changes may result in fascia’s inability to resist 
normal tensile loads.[40, 41] 
- Associated with increased heel fat pad thickness & loss of elasticity.[52, 54] 
- Decreased fascial elasticity associated with decreased shock absorbing 
capabilities in older patients.[54] 
Physical load on ligament: 
- Excessive foot pronation.[5, 16, 19, 25, 29, 53, 57]  
- Rearfoot eversion + arch height collapse.[47, 49] 
- Repetitive microtrauma.[52]  
 
Obesity:  
- Increased BMI[16, 97, 29, 48, 53, 55] associated with increasing heel fat pad 
thickness and loss of heel pad eleasticity.[54] 
Occupation: 
- Prolonged weight-bearing.[3, 5, 19, 35, 40] 
- Change in walking or running surface.[5] 
Table
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- Significant positive correlation between BMI and PF thickness causing 
chronic stretch, overloading & focal pressure of PF.[10, 65, 66] 
- Standing on hard surfaces.[32, 40] 
Gender: 
Current literature inconsistent:  
- Increased prevalence in men.[26] 
- Increased prevalence in women.[14, 18, 29] 
Environment: 
- Inappropriate footwear.[2, 5, 19, 48] 
Ethnicity: No reported associations.   
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Biomechanical dysfunction & anatomical variants: 
- Reduced range of ankle joint secondary to tight Achilles tendon strains 
plantar fascia.[3, 5, 16, 29, 32, 53] Riddle et al[19] considers this the most 
important risk factor. 
- Tightness of posterior lower limb muscles[41, 51, 56] and specifically 
hamstring tightness.[33, 46] 
- Decreased 1st MPJ range of extension due to tight Achilles tendon.[5, 35] 
- Flexor digitorum brevis tendinopathy secondary to stress shielding.[14]   
- Calcaneal spur. [7, 9, 10, 42-45]  
- Plantar fascial thickening [50]  
Lifestyle: 
Rapid increases in activity levels allied to physical demands 
of sport or occupation.[5, 19] 
 
Sleeping posture: 
Can contribute to posterior leg muscle contraction.[51, 67] 
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Acquired systemic diseases: 
- No association with systemic factors.[1, 5] 
- Rheumatoid arthritis.[67] 
- Ankylosing spondylitis.[3, 9, 67] 
- Diabetes mellitus where micro/macro vascular impairment results in 
accelerated fasciosis.[9]  
-  Chemotherapy, retroviral infection & rarely gonococcus & TB.[9] 
Sport: 
- Overuse injury combined with running surface.[22] 
- Poor technique.[26] 
- Training errors.[30] 
- High intensity.[5] 
- Fatigue.[25] 
- Repetitive loading.[22] 
- Muscle dysfunction and inflexibility.[30, 25] 
Major trauma (Laceration/puncture wound, previous foot surgery).  
No reported associations 
 
Oestrogen levels: 
- Low oestrogen levels in female athletes leads to reducted collagen 
elasticity.[52] 
 
Vascular perfusion of ligament:  
- Reduced vascular supply to plantar fascia & subsequent poor nutrition.[12] 
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Fluoroquinolone antibiotics:  
A tendon (Achilles) association exists[68] but none in ligaments to-date. 
 
Inherited systemic diseases: 
No association has been reported. 
 
Genetic: 
Potential candidate gene variants (based on tendon studies): 
- COL5A1.[58] 
- MMP1.[59, 60] 
- MMP3.[60, 61] 
- MMP8.[60] 
- MMP10 & MMP12.[59, 60]  
- GDF5.[60] 
- TGFB.[62]  
- ADAMTS1, ADAMTS2, ADAMTS4, ADAMTS5, ADAMTS15.[63, 64] 
- TIMP1, TIMP2, TIMP3, TIMP4.[60] 
 
 
